| Khaki |
2011 |
Evaluation of viral antibodies in Iranian multiple sclerosis patients |
| Vandenbroeck |
2011 |
Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection |
| Garcia-Montojo |
2011 |
Human herpesvirus 6 and effectiveness of interferon beta 1b in multiple sclerosis patients |
| Behzad-Behbahani |
2009 |
Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis |
| Ahram |
2009 |
Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients |
| Alvarez-Lafuente |
2008 |
Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients |
| Alvarez-Lafuente |
2006 |
Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients |
| Martínez |
2007 |
Environment–gene interaction in multiple sclerosis: Human herpesvirus 6 and MHC2TA |
| Hollsberg |
2005 |
Presence of Epstein–Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity |
| Chapenko |
2003 |
Correlation Between HHV-6 Reactivation and Multiple Sclerosis Disease Activity |
| Goodman |
2003 |
Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions |
| Berti |
2002 |
Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression |
| Ablashi |
1998 |
Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report |
| Soldan |
1997 |
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA |
| Challoner |
1995 |
Plaque-associated expression of human herpesvirus 6 in multiple sclerosis |